A Qualitative Study of Antipsychotic Medication Experiences of Youth

被引:0
作者
Murphy, Andrea L. [1 ,2 ]
Gardner, David M. [1 ,2 ]
Kisely, Steve [3 ]
Cooke, Charmaine [4 ]
Kutcher, Stan P. [2 ,5 ]
Hughes, Jean [6 ]
机构
[1] Dalhousie Univ, Coll Pharm, Halifax, NS B3H 3J5, Canada
[2] Dalhousie Univ, Dept Psychiat, Halifax, NS, Canada
[3] Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia
[4] Dept Hlth & Wellness, Halifax, NS, Canada
[5] Dalhousie Univ, IWK Hlth Ctr, Sun Life Financial Chair Adolescent Mental Hlth, Halifax, NS, Canada
[6] Dalhousie Univ, Sch Nursing, Halifax, NS, Canada
关键词
antipsychotic agents; qualitative research; pediatrics; young adults; physician-patient relations; decision-making;
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: To explore the lived experience of youth who are prescribed antipsychotics. Methods: We conducted an interpretive phenomenology study of young people with recent experience of taking antipsychotics. Youth were interviewed and a staged approach was used for data analysis of transcriptions. We collected approximately 13 hours of audio from 18 youth aged 13 to 26 years between January and August of 2010. Results: Ambivalence was significant and antipsychotic adverse effects frequently tempered benefits. Both illness and antipsychotics had significant impacts on physical and mental wellbeing with adverse effects on relationships and functioning in various contexts (e.g., school). Stigma related to both antipsychotics and illness was also prominent. Participants' limited knowledge about their antipsychotics and pressure to conform within their youth culture and context affected decisions on starting, adhering to, and persisting with treatment. Conclusions: The lived experience of youth taking antipsychotics is complex and the benefits (e.g., symptom improvement) and consequences (e.g., adverse effects) associated with antipsychotics affect all facets of life. More research is needed to better understand youth priorities in treatment decisions and whether youth who demonstrate substantive gaps in their knowledge about antipsychotics are truly given the opportunity to be informed and engage in management decisions including whether to initiate, persist with, and discontinue treatments.
引用
收藏
页码:61 / 69
页数:9
相关论文
共 42 条
  • [1] Ten Years of Antipsychotic Prescribing to Children: A Canadian Population-Based Study
    Alessi-Severini, Silvia
    Biscontri, Robert G.
    Collins, David M.
    Sareen, Jitender
    Enns, Murray W.
    [J]. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2012, 57 (01): : 52 - 58
  • [2] BENNER P, 1985, ADV NURS SCI, V8, P1
  • [3] Canadian Adverse Reaction Newsletter, 2012, 2 GEN ANT CARD ADV R
  • [4] Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model
    Charles, C
    Gafni, A
    Whelan, T
    [J]. SOCIAL SCIENCE & MEDICINE, 1999, 49 (05) : 651 - 661
  • [5] Chow S, 2009, SHARED DECISION MAKI
  • [6] Cook JA., 2002, J DISABIL POLICY STU, V13, P88, DOI [10.1177/10442073020130020401, DOI 10.1177/10442073020130020401]
  • [7] Trends in prescribing of antipsychotic medications for US children
    Cooper, WO
    Arbogast, PG
    Ding, H
    Hickson, GB
    Fuchs, DC
    Ray, WA
    [J]. AMBULATORY PEDIATRICS, 2006, 6 (02) : 79 - 83
  • [8] Determining validity in qualitative inquiry
    Creswell, JW
    Miller, DL
    [J]. THEORY INTO PRACTICE, 2000, 39 (03) : 124 - 130
  • [9] Diekelmann N., 1989, HERMENEUTIC ANAL NLN, P11
  • [10] FLOERSCH J, 2003, SOCIAL WORK MENTAL H, V1, P51, DOI DOI 10.1300/J200V01N04_04